ArticleHaematologica2018

Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.

Jingsong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.